Recombinant Human BTG2 Protein，His

BTG2 (B-cell translocation gene 2) is a member of the BTG family of proteins, which are known for their roles in regulating cell cycle progression, differentiation, and apoptosis. Research on BTG2 has gained momentum due to its potential implications in cancer biology and other diseases. Specifically, BTG2 functions as a tumor suppressor, inhibiting cell proliferation and promoting apoptosis in various cancer types, including breast and colorectal cancers. Its expression is often downregulated in cancerous tissues, which correlates with poor prognosis and aggressive tumor behavior. Recombination and expression studies of BTG2 have been pivotal in elucidating its molecular mechanisms, involving the regulation of genes associated with cell growth and survival. Moreover, BTG2's interactions with other signaling pathways, such as the p53 tumor suppressor pathway, underscore its importance in maintaining cellular homeostasis. Understanding the structure and function of recombinantly expressed BTG2 can provide insights into its role in tumorigenesis and may reveal potential therapeutic targets for cancer treatment. Additionally, the study of BTG2’s role in cellular response to stress and differentiation emphasizes its relevance beyond cancer, potentially contributing to the understanding of neurodegenerative diseases and developmental processes. Overall, the investigation of BTG2 recombinant proteins offers a promising avenue for advancing our knowledge of its biological functions and therapeutic applications.